• Zosano Pharma’s (ZSAN) “Buy” Rating Reiterated at Zacks Investment Research

    Zacks Investment Research reissued their buy rating on shares of Zosano Pharma (NASDAQ:ZSAN) in a research note published on Saturday, …

  • 0 0